{"transactions":[{"id":1558880,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":6376,"derivative":{"underlying":"Common Stock","underlying_shares":192},"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558879,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F4","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":8250,"derivative":{"underlying":"Common Stock","underlying_shares":249},"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558878,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":false,"shares":18750,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested 25% on the one-year anniversary of the grant date and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":56250,"derivative":{"underlying":"Common Stock","underlying_shares":18750},"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558877,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"tax_withholding","planned":false,"acquired":false,"shares":6085,"price":4.06,"value":24705.1,"ownership":{"direct":true},"footnotes":[{"field":"acquired","element":"transactionAcquiredDisposedCode","label":"F2","text":"Represents shares withheld by the Issuer to satisfy the mandatory tax withholding requirements upon vesting of the RSUs. This is not an open market sale of securities."}],"balance_after":21140,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558876,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":27225,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558875,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":26588,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1558874,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2024-03-29T01:00:08.000Z","date":"2024-03-26","kind":"exercise","planned":false,"acquired":true,"shares":18750,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":25763,"source":{"system":"sec-edgar","filing":"0001493152-24-011836","document":"ownership.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011836/ownership.xml","form_type":"4"}},{"id":1562526,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2024-03-26T01:30:11.000Z","date":"2024-03-21","kind":"grant","planned":false,"acquired":true,"shares":370000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 21, 2025 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":370000,"derivative":{"exercise_price":4.37,"expiration_date":"2034-03-21","underlying":"Common Stock","underlying_shares":370000},"source":{"system":"sec-edgar","filing":"0001493152-24-011215","document":"ownership.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000149315224011215/ownership.xml","form_type":"4"}},{"id":1701461,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-12-22T21:17:28.000Z","date":"2023-12-20","kind":"exercise","planned":false,"acquired":false,"shares":637,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs vested 25% on September 20, 2023 and the remainder vested or shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":7013,"derivative":{"underlying":"Common Stock","underlying_shares":637},"source":{"system":"sec-edgar","filing":"0001209191-23-059558","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123059558/doc4.xml","form_type":"4"}},{"id":1701460,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-22T21:17:28.000Z","date":"2023-12-21","kind":"sale","planned":false,"acquired":false,"shares":206,"price":2.46,"value":506.76,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $2.4602 to $2.485 inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote."}],"balance_after":5286,"source":{"system":"sec-edgar","filing":"0001209191-23-059558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123059558/doc4.xml","form_type":"4"}},{"id":1701459,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-22T21:17:28.000Z","date":"2023-12-20","kind":"exercise","planned":false,"acquired":true,"shares":637,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":5492,"source":{"system":"sec-edgar","filing":"0001209191-23-059558","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123059558/doc4.xml","form_type":"4"}},{"id":1711498,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-12-14T21:01:11.000Z","date":"2023-12-07","kind":"sale","planned":false,"acquired":false,"shares":1820,"price":2.5,"value":4550.0,"ownership":{"direct":true},"footnotes":[{"field":"shares","element":"transactionShares","label":"F1","text":"Reflects shares sold to cover withholding taxes incurred upon the vesting and settlement of restricted stock units in a trade that was initiated by the Issuer on the Reporting Person's behalf."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in column 4 is a weighted average price. The shares were purchased in multiple transactions at prices ranging from $2.48 to $2.50, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the range specified in this footnote."}],"balance_after":4855,"source":{"system":"sec-edgar","filing":"0001104659-23-126020","document":"tm2332941-1_4seq1.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000110465923126020/tm2332941-1_4seq1.xml","form_type":"4"}},{"id":1768882,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-10-03T20:36:35.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":false,"shares":825,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":9075,"derivative":{"underlying":"Common Stock","underlying_shares":825},"source":{"system":"sec-edgar","filing":"0001209191-23-051502","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123051502/doc4.xml","form_type":"4"}},{"id":1768881,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-10-03T20:36:35.000Z","date":"2023-10-01","kind":"exercise","planned":false,"acquired":true,"shares":825,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":6675,"source":{"system":"sec-edgar","filing":"0001209191-23-051502","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123051502/doc4.xml","form_type":"4"}},{"id":1775035,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-09-22T20:34:17.000Z","date":"2023-09-20","kind":"exercise","planned":false,"acquired":false,"shares":2550,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":7650,"derivative":{"underlying":"Common Stock","underlying_shares":2550},"source":{"system":"sec-edgar","filing":"0001209191-23-050379","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123050379/doc4.xml","form_type":"4"}},{"id":1775034,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-09-22T20:34:17.000Z","date":"2023-09-20","kind":"exercise","planned":false,"acquired":true,"shares":2550,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":5850,"source":{"system":"sec-edgar","filing":"0001209191-23-050379","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123050379/doc4.xml","form_type":"4"}},{"id":1837893,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-07-05T20:18:04.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":false,"shares":3300,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"The RSUs vested 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":9900,"derivative":{"underlying":"Common Stock","underlying_shares":3300},"source":{"system":"sec-edgar","filing":"0001209191-23-041027","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123041027/doc4.xml","form_type":"4"}},{"id":1837892,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Common Stock","published_at":"2023-07-05T20:18:04.000Z","date":"2023-07-01","kind":"exercise","planned":false,"acquired":true,"shares":3300,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":3300,"source":{"system":"sec-edgar","filing":"0001209191-23-041027","document":"doc4.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123041027/doc4.xml","form_type":"4"}},{"id":1938364,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Restricted Stock Units","published_at":"2023-03-27T21:26:54.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":75000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on March 23, 2024 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."}],"balance_after":75000,"derivative":{"underlying":"Common Stock","underlying_shares":75000},"source":{"system":"sec-edgar","filing":"0001209191-23-021257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021257/doc4.xml","form_type":"4"}},{"id":1938363,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Executive Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2023-03-27T21:26:54.000Z","date":"2023-03-23","kind":"grant","planned":false,"acquired":true,"shares":150000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on March 23, 2024 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":150000,"derivative":{"exercise_price":4.84,"expiration_date":"2033-03-23","underlying":"Common Stock","underlying_shares":150000},"source":{"system":"sec-edgar","filing":"0001209191-23-021257","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919123021257/doc4.xml","form_type":"4"}},{"id":2152989,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-09-22T20:06:47.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":10200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on September 20, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":10200,"derivative":{"underlying":"Common Stock","underlying_shares":10200},"source":{"system":"sec-edgar","filing":"0001209191-22-051003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051003/doc4.xml","form_type":"4"}},{"id":2152988,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":true,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-09-22T20:06:47.000Z","date":"2022-09-20","kind":"grant","acquired":true,"shares":60900,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on September 20, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":60900,"derivative":{"exercise_price":3.5,"expiration_date":"2032-09-20","underlying":"Common Stock","underlying_shares":60900},"source":{"system":"sec-edgar","filing":"0001209191-22-051003","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122051003/doc4.xml","form_type":"4"}},{"id":2205748,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Restricted Stock Units","published_at":"2022-07-19T20:36:48.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":13200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_price","element":"conversionOrExercisePrice","label":"F2","text":"Each restricted stock unit (\"RSU\") represents a contingent right to receive one share of Issuer common stock."},{"field":"derivative.exercise_date","element":"exerciseDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."},{"field":"derivative.expiration_date","element":"expirationDate","label":"F3","text":"The RSUs shall vest 25% on July 1, 2023 and the remainder shall vest in 12 equal quarterly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":13200,"derivative":{"underlying":"Common Stock","underlying_shares":13200},"source":{"system":"sec-edgar","filing":"0001209191-22-042571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042571/doc4.xml","form_type":"4"}},{"id":2205747,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"Chief Operating Officer"}}],"security":"Employee Stock Option (right to buy)","published_at":"2022-07-19T20:36:48.000Z","date":"2022-07-15","kind":"grant","acquired":true,"shares":79200,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"The shares underlying the option shall vest 25% on July 1, 2023 and the remainder shall vest in 36 equal monthly installments thereafter, subject to Reporting Person's continuous service through each such vesting date."}],"balance_after":79200,"derivative":{"exercise_price":4.01,"expiration_date":"2032-07-15","underlying":"Common Stock","underlying_shares":79200},"source":{"system":"sec-edgar","filing":"0001209191-22-042571","document":"doc4.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000120919122042571/doc4.xml","form_type":"4"}},{"id":2458097,"issuer":{"id":6943,"kind":"organization","name":"Gain Therapeutics, Inc."},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"CHIEF OPERATING OFFICER"}}],"security":"Non Qualified Stock Option (right to buy)","published_at":"2021-12-28T21:30:21.000Z","date":"2021-12-23","kind":"grant","acquired":true,"shares":200000,"price":5.86,"value":1172000.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F1","text":"50,000 options shall vest on 10/15/2022 (the \"Initial Vesting Date\") and the remaining 150,000 options shall vest in a series of thirty-six (36) successive equal monthly installments on each subsequent monthly anniversary of the Initial Vesting Date."}],"balance_after":200000,"derivative":{"exercise_price":5.86,"exercise_date":"2022-10-15","expiration_date":"2032-10-15","underlying":"Common Stock","underlying_shares":200000},"source":{"system":"sec-edgar","filing":"0001415889-21-006258","document":"form4-12282021_041202.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1819411/000141588921006258/form4-12282021_041202.xml","form_type":"4"}},{"id":4260729,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Council & Sec."}}],"security":"Common Stock, Class A (ESPP)","published_at":"2017-07-07T16:30:14.000Z","date":"2017-06-30","kind":"grant","acquired":true,"shares":673,"price":8.93,"value":6009.89,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period April 1, 2017 through June 30, 2017. This transaction is exempt under Rule 16(b)-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at 85% of the June 30, 2017 closing price of the issuer's common stock."}],"balance_after":4763,"source":{"system":"sec-edgar","filing":"0001171843-17-003999","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184317003999/formfour.xml","form_type":"4"}},{"id":4326369,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Gen. Council & Sec."}}],"security":"Common Stock, Class A (ESPP)","published_at":"2017-05-10T16:01:44.000Z","date":"2017-03-31","kind":"grant","acquired":true,"shares":641,"price":9.35,"value":5993.35,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period January 1, 2017 through March 31, 2017. This transaction is exempt under Rule 16(b)-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at 85% of the March 31, 2017 closing price of the issuer's common stock."}],"balance_after":4224,"source":{"system":"sec-edgar","filing":"0001171843-17-002917","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184317002917/formfour.xml","form_type":"4"}},{"id":4394444,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus.Dev.&Lic., GC & Sec"}}],"security":"Employee Stock Option (right to buy)","published_at":"2017-03-08T17:01:18.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":63000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F2","text":"The option will vest over a four-year period, with 25% vesting on March 2, 2018 and the remaining 75% vesting in equal monthly increments over the three-year period thereafter."}],"balance_after":325500,"derivative":{"exercise_price":11.85,"expiration_date":"2027-03-02","underlying":"Class A Common Stock","underlying_shares":63000},"source":{"system":"sec-edgar","filing":"0001171843-17-001360","document":"f4_alder030817.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184317001360/f4_alder030817.xml","form_type":"4"}},{"id":4394443,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus.Dev.&Lic., GC & Sec"}}],"security":"Common stock","published_at":"2017-03-08T17:01:18.000Z","date":"2017-03-06","kind":"grant","acquired":true,"shares":33000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"Common stock granted consists of restricted stock units that vest on March 2, 2020."}],"balance_after":33000,"source":{"system":"sec-edgar","filing":"0001171843-17-001360","document":"f4_alder030817.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184317001360/f4_alder030817.xml","form_type":"4"}},{"id":4496036,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A (ESPP)","published_at":"2017-01-06T16:01:31.000Z","date":"2016-12-31","kind":"grant","acquired":true,"shares":134,"price":10.46,"value":1401.64,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period October 1, 2016 through December 31, 2016. This transaction is exempt under Rule 16(b)-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at 85% of the September 30, 2016 closing price of the issuer's common stock."}],"balance_after":3583,"source":{"system":"sec-edgar","filing":"0001171843-17-000122","document":"formfour.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184317000122/formfour.xml","form_type":"4"}},{"id":4540882,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-28","kind":"exercise","acquired":false,"shares":24975,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"62,996 options became exercisable on 10/27/15, and 62,996 options became exercisable on 10/27/16."}],"balance_after":262500,"derivative":{"exercise_price":8.33,"expiration_date":"2024-10-27","underlying":"Class A Common Stock","underlying_shares":24975},"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":9,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540881,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-25","kind":"exercise","acquired":false,"shares":99025,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"62,996 options became exercisable on 10/27/15, and 62,996 options became exercisable on 10/27/16."}],"balance_after":287475,"derivative":{"exercise_price":8.33,"expiration_date":"2024-10-27","underlying":"Class A Common Stock","underlying_shares":99025},"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":8,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540880,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Employee Stock Option (right to buy)","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-23","kind":"exercise","acquired":false,"shares":26000,"price":0,"value":0.0,"ownership":{"direct":true},"footnotes":[{"field":"derivative.exercise_date","element":"exerciseDate","label":"F4","text":"62,996 options became exercisable on 10/27/15, and 62,996 options became exercisable on 10/27/16."}],"balance_after":386500,"derivative":{"exercise_price":8.33,"expiration_date":"2024-10-27","underlying":"Class A Common Stock","underlying_shares":26000},"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"derivative","row_type":"transaction","position":7,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540879,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-28","kind":"sale","acquired":false,"shares":24975,"price":16.73,"value":417831.75,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F3","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $16.15 to $17.45, inclusive. The reporting person will, upon request, provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3449,"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":6,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540878,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-28","kind":"exercise","acquired":true,"shares":24975,"price":8.33,"value":208041.75,"ownership":{"direct":true},"balance_after":28424,"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":5,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540877,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-25","kind":"sale","acquired":false,"shares":99025,"price":15.88,"value":1572517.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F2","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.40 to $16.20, inclusive. The reporting person will, upon request, provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3449,"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":4,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540876,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-25","kind":"exercise","acquired":true,"shares":99025,"price":8.33,"value":824878.25,"ownership":{"direct":true},"balance_after":102474,"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":3,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540875,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-23","kind":"sale","acquired":false,"shares":26000,"price":15.77,"value":410020.0,"ownership":{"direct":true},"footnotes":[{"field":"price","element":"transactionPricePerShare","label":"F1","text":"The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $15.65 to $15.88, inclusive. The reporting person will, upon request, provide Sucampo Pharmaceuticals, Inc., any security holder of Sucampo Pharmaceuticals, Inc. or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price within the range."}],"balance_after":3449,"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":2,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4540874,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A","published_at":"2016-11-28T21:30:14.000Z","date":"2016-11-23","kind":"exercise","acquired":true,"shares":26000,"price":8.33,"value":216580.0,"ownership":{"direct":true},"balance_after":29449,"source":{"system":"sec-edgar","filing":"0001171843-16-013396","document":"f4_alder112816.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316013396/f4_alder112816.xml","form_type":"4"}},{"id":4576076,"issuer":{"id":169352,"kind":"organization","name":"Sucampo Pharmaceuticals, Inc.","symbol":"SCMP"},"owners":[{"id":92587,"kind":"person","name":"Alder Matthias","position":1,"cik":"0001370820","reported_name":"Alder Matthias","relationship":{"director":false,"officer":true,"ten_percent_owner":false,"other":false,"officer_title":"EVP, Bus. Dev.&Lic, G.C. &Sec."}}],"security":"Common Stock, Class A (ESPP)","published_at":"2016-10-21T16:05:21.000Z","date":"2016-09-30","kind":"grant","acquired":true,"shares":639,"price":9.38,"value":5993.82,"ownership":{"direct":true},"footnotes":[{"field":"security","element":"securityTitle","label":"F1","text":"The reporting person is voluntarily reporting the acquisition of common stock pursuant to the issuer's Employee Stock Purchase Plan (ESPP) for the period July 1, 2016 through September 30, 2016. This transaction is exempt under Rule 16(b)-3(c)."},{"field":"price","element":"transactionPricePerShare","label":"F2","text":"In accordance with the ESPP, these shares were purchased at 85% of the July 1, 2016 closing price of the issuer's common stock."}],"balance_after":3449,"source":{"system":"sec-edgar","filing":"0001171843-16-012572","document":"f4_alder102116.xml","document_sequence":1,"table":"nonDerivative","row_type":"transaction","position":1,"url":"https://www.sec.gov/Archives/edgar/data/1365216/000117184316012572/f4_alder102116.xml","form_type":"4"}}]}